Literature DB >> 28161804

Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways.

Theodoros Eleftheriadis1, Georgios Pissas2, Maria Sounidaki2, Georgia Antoniadi2, Christos Rountas3, Vassilios Liakopoulos2, Loannis Stefanidis2.   

Abstract

In atherosclerosis-associated pathologic entities characterized by malnutrition and inflammation, L-tryptophan (TRP) levels are low. Insulin resistance is an independent cardiovascular risk factor and induces endothelial dysfunction by increasing fatty acid oxidation. It is also associated with inflammation and low TRP levels. Low TRP levels have been related to worse cardiovascular outcome. This study evaluated the effect of TRP depletion on endothelial dysfunction under conditions that imitate insulin resistance. Fatty acid oxidation, harmful pathways due to increased fatty acid oxidation, and endothelial dysfunction were assessed in primary human aortic endothelial cells cultured under normal glucose, low insulin conditions in the presence or absence of TRP. TRP depletion activated general control non-derepressible 2 kinase and inhibited aryl hydrocarbon receptor. It increased fatty acid oxidation by increasing expression and activity of carnitine palmitoyltransferase 1. Elevated fatty acid oxidation increased the formation of reactive oxygen species (ROS) triggering the polyol and hexosamine pathways, and enhancing protein kinase C activity and methylglyoxal production. TRP absence inhibited nitric oxide synthase activity in a ROS-dependent way, whereas it increased the expression of ICAM-1 and VCAM-1 in a ROS independent and possibly p53-dependent manner. Thus, TRP depletion, an amino acid whose low levels have been related to worse cardiovascular outcome and to inflammatory atherosclerosis-associated pathologic entities, under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through ROS-dependent and independent pathways. These findings may offer new insights at the molecular mechanisms involved in accelerated atherosclerosis that frequently accompanies malnutrition and inflammation.

Entities:  

Keywords:  Atherosclerosis; Endothelial dysfunction; Fatty acid oxidation; Inflammation; Insulin resistance; ROS; Tryptophan depletion

Mesh:

Substances:

Year:  2017        PMID: 28161804     DOI: 10.1007/s11010-016-2915-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  69 in total

1.  Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease.

Authors:  Theodoros Eleftheriadis; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis; Grammati Galaktidou
Journal:  Ren Fail       Date:  2011-10-21       Impact factor: 2.606

2.  Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Georgia Antoniadi; Aginor Spanoulis; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Int Immunol       Date:  2014-07-26       Impact factor: 4.823

3.  Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells.

Authors:  Tae Jin Yun; Jun Seong Lee; Kawthar Machmach; Dahee Shim; Junhee Choi; Young Jin Wi; Hyung Seok Jang; In-Hyuk Jung; Kyeongdae Kim; Won Kee Yoon; Mohammad Alam Miah; Bin Li; Jinsam Chang; Mariana G Bego; Tram N Q Pham; Jakob Loschko; Jörg Hermann Fritz; Anne B Krug; Seung-Pyo Lee; Tibor Keler; Jean V Guimond; Elie Haddad; Eric A Cohen; Martin G Sirois; Ismail El-Hamamsy; Marco Colonna; Goo Taeg Oh; Jae-Hoon Choi; Cheolho Cheong
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

4.  Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.

Authors:  Weiwei Qin; Yonggang Lu; Chengyan Zhan; Tao Shen; Lin Dou; Yong Man; Shu Wang; Chuanshi Xiao; Yunfei Bian; Jian Li
Journal:  Cardiovasc Drugs Ther       Date:  2012-02       Impact factor: 3.727

5.  Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.

Authors:  Jennifer E Cole; Nagore Astola; Adam P Cribbs; Michael E Goddard; Inhye Park; Patricia Green; Alun H Davies; Richard O Williams; Marc Feldmann; Claudia Monaco
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

6.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

Review 7.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Nat Cell Biol       Date:  2011-09-02       Impact factor: 28.824

8.  Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways.

Authors:  Theodoros Eleftheriadis; Konstantina Tsogka; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Int Urol Nephrol       Date:  2016-07-27       Impact factor: 2.370

Review 9.  Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.

Authors:  M Schreurs; F Kuipers; F R van der Leij
Journal:  Obes Rev       Date:  2009-08-20       Impact factor: 9.213

Review 10.  Hemodynamic actions of insulin.

Authors:  A D Baron
Journal:  Am J Physiol       Date:  1994-08
View more
  6 in total

1.  Allopurinol protects human glomerular endothelial cells from high glucose-induced reactive oxygen species generation, p53 overexpression and endothelial dysfunction.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Int Urol Nephrol       Date:  2017-11-01       Impact factor: 2.370

2.  Indoleamine 2, 3-dioxygenase (IDO) increases during renal fibrogenesis and its inhibition potentiates TGF-β 1-induced epithelial to mesenchymal transition.

Authors:  Luiz Henrique Gomes Matheus; Gislene Mendes Simão; Taíssa Altieri Amaral; Rodrigo Barbosa Oliveira Brito; Camila Soares Malta; Yves Silva Teles Matos; Alexandre Chagas Santana; Gabriela Gomes Cardoso Rodrigues; Maria Clara Albejante; Erna Elisabeth Bach; Maria Aparecida Dalboni; Cleber Pinto Camacho; Humberto Dellê
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

3.  What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?

Authors:  Theodoros Eleftheriadis
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

4.  Nifedipine Exacerbates Lipogenesis in the Kidney via KIM-1, CD36, and SREBP Upregulation: Implications from an Animal Model for Human Study.

Authors:  Yen-Chung Lin; Jhih-Cheng Wang; Mai-Szu Wu; Yuh-Feng Lin; Chang-Rong Chen; Chang-Yu Chen; Kuan-Chou Chen; Chiung-Chi Peng
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

5.  Inhibition of acetyl-CoA carboxylase by PP-7a exerts beneficial effects on metabolic dysregulation in a mouse model of diet-induced obesity.

Authors:  Tianya Liu; Lingshan Gou; Shirong Yan; Tonghui Huang
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

Review 6.  The Role of Amino Acids in Endothelial Biology and Function.

Authors:  Meng Li; Yanqing Wu; Lei Ye
Journal:  Cells       Date:  2022-04-18       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.